NOVOZYMES -B- (NZM2 MU) stock market data APIs
€57.5267
-0.01(-0%)
as of September 15, 2026
Try our APIs with
free plan!
NOVOZYMES -B- Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for NZM2.MU.
Prev. Close
57.5267
Open
57.5187
High
57.5668
Low
57.4386
52 wk Range
45.1952-62
Market Cap
19 321 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get NOVOZYMES -B- data using free add-ons & libraries
Get NOVOZYMES -B- Fundamental Data
NOVOZYMES -B- Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-20
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
NOVOZYMES -B- News
New
Novozymes (CPSE:NSIS B) Could Be 13% Undervalued After €600 Million Patalganga Expansion
Expansion in Patalganga puts Novozymes under the spotlight Novozymes (CPSE:NSIS B) has come into focus after Novonesis announced a €600 million plan to expand its Patalganga site, with the aim of i...
Initiation of Novonesis’ share buyback program
Novonesis (Novozymes A/S) Today, Novonesis will initiate the first tranche (the "First Tranche") of the EUR 1 billion multi-year share buyback program announced in Company Announcement No. 14, on Aug...
Novonesis to build next generation enzyme production facility in India
Novonesis (Novozymes A/S) Novonesis will invest €600 million to expand its site in Patalganga and build a state-of-the-art facility. This marks another step in the company's long-term growt...
Novonesis (Novozymes) B's Dividend Analysis
This article first appeared on GuruFocus. Assessing the Sustainability and Growth of NVZMY's Upcoming Dividend Payment Novonesis (Novozymes) B (NVZMY) recently announced a total dividend of $0.37 pe...
Get NOVOZYMES -B- fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
